期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Safety and efficacy of transcatheter arterial embolization for management of refractory hematuria of prostatic origin
1
作者 Jinlong Zhang Quanyu Wang +5 位作者 Hongwei Zhao Bing Yuan Xuedong Sun Yang Guan Zhuting Fang Maoqiang Wang 《Journal of Interventional Medicine》 2022年第2期84-88,共5页
Objective: To estimate the safety and efficacy of transcatheter arterial embolization(TAE) in the treatment of refractory hematuria of prostatic origin(RHPO).Methods: This retrospective study included 23 patients who ... Objective: To estimate the safety and efficacy of transcatheter arterial embolization(TAE) in the treatment of refractory hematuria of prostatic origin(RHPO).Methods: This retrospective study included 23 patients who underwent TAE for RHPO between May 2013 and August 2021. Technical and clinical success rates were calculated, and arteriogram findings and complications were detected.Results: Embolization was performed 24 times in 23 patients. Technical success was achieved in 24/24(100%)embolization procedures. Contrast agent extravasation was detected during 2 of the 24 angiographic procedures.Bilateral embolization was performed in 23(95.8%) of the 24 procedures. The clinical success rate was 21/23(91.3%), and hematuria stopped 1–4 days after TAE. No serious complications were observed.Conclusion: TAE is a safe and effective minimally invasive technique for treating patients with RHPO. 展开更多
关键词 Transcatheter arterial embolization HEMATURIA Benign prostatic hyperplasia
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部